EFFECTS OF EP-RECEPTOR SUBTYPE SPECIFIC AGONISTS AND OTHER PROSTANOIDS ON ADENYLATE-CYCLASE ACTIVITY OF DUODENAL EPITHELIAL-CELLS
EFFECTS OF EP-RECEPTOR SUBTYPE SPECIFIC AGONISTS AND OTHER PROSTANOIDS ON ADENYLATE-CYCLASE ACTIVITY OF DUODENAL EPITHELIAL-CELLS
复制标题
DOI:
10.1016/0090-6980(92)90142-g
复制
发表时间:
1992-11-01
期刊:
影响因子:
--
通讯作者:
SEWING, KF
中科院分区:
文献类型:
--
作者:
REIMER, R;HEIM, HK;SEWING, KF
Rank order of agonist potency for activation of adenylate cyclase by the naturally occurring prostanoids PGE2, PGF2alpha, PGD2, the stable PGI2 analogue iloprost, and the TXA2 mimetic U 46619, provides evidence for the existence of a distinct PGE-receptor on guinea-pig duodenal enterocytes. This PGE-receptor is likely to be of the EP2-Subtype since the specific EP2-agonist 11-deoxy-PGE, stimulated adenylate cyclase activity with a 20-fold higher potency than the EP1-agonist 17-phenyltrinor-PGE2 and the EP3-agonists MB 28767 and GR 63799. In addition, sulprostone (acting on both EP1- and EP3-receptors) was ineffective. Since the specific EP1-antagonist SC 19220 did not inhibit PGE2-stimulated adenylate cyclase activity, the involvement of EP1-receptors could be further excluded. The synthetic prostaglandin E-analogues misoprostol and nocloprost stimulated adenylate cyclase almost identically, though they were about 10-fold less potent than the natural PGE2.